Results 231 to 240 of about 22,997 (249)

Worldwide collaboration for orphan drug designation

Nature Reviews Drug Discovery, 2016
Bruno Sepodes, Segundo Mariz, Mariz Segundo   +2 more
exaly  

Issues Aired Related to Orphan Drug Products at Washington Hearing

American Journal of Health-System Pharmacy, 1983
openaire   +1 more source

The Food and Drug Administration’s Office of Orphan Products Development: Incentives, Grants, and Special Designations Speed Therapies for Orphan Diseases

Retina, 2005
openaire   +2 more sources

A comparative study of European rare disease and orphan drug markets

Health Policy, 2010
Lut Mergaert, Steven Simoens, Irina Cleemput   +2 more
exaly  

The Committee for Orphan Medical Products of the EMEA has adopted a positive opinion recommending orphan drug designation for PI-88

Inpharma Weekly, 2007
openaire   +1 more source

Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations

Clinical Therapeutics, 2010
Stefan Vegter, Mark H Rozenbaum
exaly  

Ensuring Effectiveness, Safety, and Access to Orphan Drug Products (1821)

2019
openaire   +1 more source

When Everyone Is an Orphan: Against Adopting a U.S.-Styled Orphan Drug Policy in Canada

Accountability in Research, 2013
Matthew Herder
exaly  

Evergreening exclusive rights in pharmaceutical products: the case of SPCs, paediatric extensions and orphan drugs

2022
openaire   +1 more source

The Economics of Orphan Drug Policy in the US

Pharmacoeconomics, 2012
John Peabody, Peabody John W, J W Peabody   +2 more
exaly